![\"\"](\"https:\/\/platoai.gbaglobal.org\/wp-content\/uploads\/2023\/07\/kinnos-secures-additional-15m-funding-to-enhance-hospital-surface-disinfection.jpg\")
<\/p>\n<\/p>\n
Kinnos, a New York-based startup that specializes in enhancing hospital surface disinfection, has recently secured an additional $15 million in funding. This funding round was led by Morningside Group, a venture capital firm known for its investments in healthcare technology companies.<\/p>\n
Kinnos has developed a unique product called Highlight, which is a colorized disinfectant that improves the effectiveness of surface cleaning in hospitals. The product is designed to address the challenge of ensuring thorough disinfection in healthcare settings, where the risk of healthcare-associated infections (HAIs) is high.<\/p>\n
Highlight works by adding a color to traditional disinfectants, allowing healthcare workers to visualize the areas that have been properly disinfected. The color fades over time, indicating when it is time to reapply the disinfectant. This innovative approach helps to ensure that all surfaces are adequately cleaned, reducing the risk of HAIs and improving patient safety.<\/p>\n
The additional funding will be used by Kinnos to further enhance their product and expand its reach in the healthcare industry. The company plans to invest in research and development to improve the formulation of Highlight and explore new applications for their technology. They also aim to increase their sales and marketing efforts to promote the adoption of their product in hospitals worldwide.<\/p>\n
The COVID-19 pandemic has highlighted the importance of effective surface disinfection in healthcare settings. Hospitals have been under immense pressure to maintain a clean and safe environment for patients and healthcare workers. Kinnos’ Highlight offers a valuable solution to this challenge, providing a visual aid that ensures thorough disinfection and reduces the risk of infection transmission.<\/p>\n
The funding round led by Morningside Group demonstrates the confidence investors have in Kinnos’ technology and its potential impact on the healthcare industry. Morningside Group has a strong track record of supporting innovative healthcare startups, and their involvement further validates Kinnos’ approach to surface disinfection.<\/p>\n
Kinnos has already made significant strides in the healthcare industry, with Highlight being used in hospitals across the United States and internationally. The additional funding will enable the company to accelerate its growth and make a greater impact on patient safety.<\/p>\n
In conclusion, Kinnos’ recent $15 million funding round led by Morningside Group is a significant milestone for the company. With their innovative product, Highlight, Kinnos is revolutionizing hospital surface disinfection and improving patient safety. The funding will allow Kinnos to further enhance their technology and expand its adoption in healthcare settings worldwide. As the world continues to battle the COVID-19 pandemic and other infectious diseases, Kinnos’ solution offers a valuable tool in the fight against healthcare-associated infections.<\/p>\n
Kinnos, a New York-based startup that specializes in enhancing hospital surface disinfection, has recently secured an additional $15 million in funding. This funding round was led by Morningside Group, a venture capital firm known for its investments in healthcare technology companies. Kinnos has developed a unique product called Highlight, which is a colorized disinfectant that […]<\/p>\n","protected":false},"author":2,"featured_media":2548566,"menu_order":0,"template":"Default","format":"standard","meta":[],"aiwire-tag":[2012,1148,2881,279,3194,647,1149,789,562,4415,129,11,441,342,131,1150,17,31242,132,18,134,2156,20,649,21,6811,23,368,140,29,218,30,796,2014,7375,5849,970,727,222,2336,2558,2714,150,5483,5484,591,11829,38,157,867,9709,28713,1745,531,8019,1198,13925,347,4266,4267,235,7190,376,377,7620,26709,1206,1207,2200,2201,1219,50,13252,52,3350,2075,31239,31240,11978,29356,3146,1794,1518,55,3685,18111,386,1637,166,5116,1027,8780,13377,1031,6444,168,4673,169,12213,1800,57,170,5186,58,12638,10427,22962,1427,608,10646,1235,59,172,6295,60,61,62,1041,541,249,3415,292,67,2960,178,614,1344,1061,5189,1659,26305,73,179,6304,75,330,5056,78,184,185,764,2321,2241,489,13361,8555,355,5,10,7,31241,8,82,623,1754,2503,629,3501,4406,661,703,302,356,1686,4624,2110,1361,12252,17844,412,1549,413,706,774,11563,2986,4566,11058,99,199,5604,274,1369,1959,201,1760,840,10441,204,5974,108,109,360,110,2866,508,111,1468,557,843,2869,1297,18598,2302,117,1960,1961,429,3370,1834,119,120,4645,1997,9315,19566,9,435,1838,124,125,3954,1306,362,1307,3019,6],"aiwire":[2873],"_links":{"self":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2548565"}],"collection":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire"}],"about":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/types\/platowire"}],"author":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2548565\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media\/2548566"}],"wp:attachment":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media?parent=2548565"}],"wp:term":[{"taxonomy":"aiwire-tag","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire-tag?post=2548565"},{"taxonomy":"aiwire","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire?post=2548565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}